MX366230B - Composiciones multipolimericas para liberación transdermica de farmaco. - Google Patents
Composiciones multipolimericas para liberación transdermica de farmaco.Info
- Publication number
- MX366230B MX366230B MX2015008286A MX2015008286A MX366230B MX 366230 B MX366230 B MX 366230B MX 2015008286 A MX2015008286 A MX 2015008286A MX 2015008286 A MX2015008286 A MX 2015008286A MX 366230 B MX366230 B MX 366230B
- Authority
- MX
- Mexico
- Prior art keywords
- polymer
- drug delivery
- polymer compositions
- transdermal drug
- compositions
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000013271 transdermal drug delivery Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000011159 matrix material Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229920002367 Polyisobutene Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229920000058 polyacrylate Polymers 0.000 abstract 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261747117P | 2012-12-28 | 2012-12-28 | |
| PCT/US2013/077934 WO2014106016A1 (en) | 2012-12-28 | 2013-12-27 | Multi-polymer compositions for transdermal drug delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015008286A MX2015008286A (es) | 2015-12-09 |
| MX366230B true MX366230B (es) | 2019-07-03 |
Family
ID=49956518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008286A MX366230B (es) | 2012-12-28 | 2013-12-27 | Composiciones multipolimericas para liberación transdermica de farmaco. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9295726B2 (https=) |
| EP (1) | EP2938335B1 (https=) |
| JP (1) | JP6359032B2 (https=) |
| AU (1) | AU2013370297A1 (https=) |
| CA (1) | CA2896347A1 (https=) |
| ES (1) | ES2864327T3 (https=) |
| MX (1) | MX366230B (https=) |
| WO (1) | WO2014106016A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8614716B2 (en) | 2010-10-01 | 2013-12-24 | Apple Inc. | Recording a command stream with a rich encoding format for capture and playback of graphics content |
| US9314470B2 (en) | 2012-12-28 | 2016-04-19 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol |
| WO2014159582A1 (en) | 2013-03-14 | 2014-10-02 | Noven Pharmaceuticals, Inc | Amphetamine transdermal compositions with acrylic block copolymer |
| AR095260A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones de anfetaminas transdérmicas estables y métodos de fabricación |
| AR095259A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
| CN105607772B (zh) * | 2014-11-13 | 2020-11-03 | 现代自动车株式会社 | 触摸输入装置以及包括该装置的车辆 |
| AU2016215180B2 (en) | 2015-02-06 | 2020-01-02 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
| US10406116B2 (en) | 2015-02-06 | 2019-09-10 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
| ES2769286T3 (es) | 2016-12-20 | 2020-06-25 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina |
| WO2018115010A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
| CN112533593A (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CA3101420A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| TWI888689B (zh) | 2021-01-07 | 2025-07-01 | 美商諾芬藥品公司 | 安非他命胺基甲酸鹽化合物及方法 |
| WO2022150430A1 (en) | 2021-01-07 | 2022-07-14 | Noven Pharmaceuticals, Inc. | Transdermal amphetamine compositions with low levels of carbamate |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0676321B2 (ja) * | 1987-02-18 | 1994-09-28 | 久光製薬株式会社 | クロニジン経皮投与製剤 |
| US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US5332576A (en) | 1991-02-27 | 1994-07-26 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US6024974A (en) | 1995-01-06 | 2000-02-15 | Noven Pharmaceuticals, Inc. | Composition and methods for transdermal delivery of acid labile drugs |
| US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| IL122484A0 (en) | 1995-06-07 | 1998-06-15 | Noven Pharma | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| US6210705B1 (en) | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| US20020102291A1 (en) | 1997-12-15 | 2002-08-01 | Noven Pharmaceuticals, Inc. | Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| US20030170195A1 (en) | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
| ATE288256T1 (de) | 1999-01-14 | 2005-02-15 | Noven Pharma | Dermale zusammensetzungen |
| IL159415A0 (en) | 2001-06-18 | 2004-06-01 | Noven Pharma | Enhanced drug delivery in transdermal systems |
| US20050019385A1 (en) | 2003-07-21 | 2005-01-27 | Noven Pharmaceuticals, Inc. | Composition and method for controlling drug delivery from silicone adhesive blends |
| EP1682102A2 (en) | 2003-09-10 | 2006-07-26 | Noven Pharmaceuticals, Inc. | Multi-layer transdermal drug delivery device |
| MEP23508A (en) | 2003-10-28 | 2010-06-10 | Noven Pharma | Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems |
| US8246976B2 (en) * | 2004-10-08 | 2012-08-21 | Noven Pharmaceuticals, Inc. | Transdermal delivery of drugs based on crystal size |
| WO2006041911A2 (en) | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Device transdermal administration of drugs including acrylic polymers |
| US8343538B2 (en) * | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
| JP2009528357A (ja) | 2006-02-27 | 2009-08-06 | ノーヴェン ファーマシューティカルズ インコーポレイテッド | アミノ官能性薬剤の投与のための組成物及び方法 |
| NZ576992A (en) | 2006-10-27 | 2011-02-25 | Noven Pharma | Transdermal delivery of ketoprofen polar derivatives |
| US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
| EP2506838A1 (en) | 2009-12-01 | 2012-10-10 | Noven Pharmaceuticals, INC. | Transdermal testosterone device and delivery |
| WO2012092165A1 (en) | 2010-12-29 | 2012-07-05 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery system comprising levonorgestrel acetate |
| EP2700401B1 (en) * | 2011-04-18 | 2020-01-15 | Hisamitsu Pharmaceutical Co., Inc. | Method for producing adhesive patch, and adhesive patch |
| CA2891467A1 (en) | 2012-10-15 | 2014-04-24 | Noven Pharmaceuticals, Inc. | Compositions and methods for the transdermal delivery of methylphenidate |
| ES2621915T3 (es) | 2012-10-25 | 2017-07-05 | Noven Pharmaceuticals, Inc. | Composiciones y métodos para la administración transdérmica de anfetamina |
| US9314470B2 (en) | 2012-12-28 | 2016-04-19 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol |
| MX2015008284A (es) | 2012-12-28 | 2015-12-03 | Noven Pharma | Composiciones y metodos para suministro transdermico de agentes no esteroidales anti-inflamatorios. |
-
2013
- 2013-12-27 MX MX2015008286A patent/MX366230B/es active IP Right Grant
- 2013-12-27 CA CA2896347A patent/CA2896347A1/en not_active Abandoned
- 2013-12-27 JP JP2015550786A patent/JP6359032B2/ja active Active
- 2013-12-27 WO PCT/US2013/077934 patent/WO2014106016A1/en not_active Ceased
- 2013-12-27 AU AU2013370297A patent/AU2013370297A1/en not_active Abandoned
- 2013-12-27 EP EP13821404.4A patent/EP2938335B1/en active Active
- 2013-12-27 US US14/141,923 patent/US9295726B2/en active Active
- 2013-12-27 ES ES13821404T patent/ES2864327T3/es active Active
-
2016
- 2016-02-17 US US15/045,951 patent/US20170007548A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013370297A1 (en) | 2015-07-16 |
| US20170007548A1 (en) | 2017-01-12 |
| JP2016504368A (ja) | 2016-02-12 |
| US20140186424A1 (en) | 2014-07-03 |
| EP2938335B1 (en) | 2021-03-17 |
| WO2014106016A1 (en) | 2014-07-03 |
| CA2896347A1 (en) | 2014-07-03 |
| ES2864327T3 (es) | 2021-10-13 |
| US9295726B2 (en) | 2016-03-29 |
| JP6359032B2 (ja) | 2018-07-18 |
| EP2938335A1 (en) | 2015-11-04 |
| MX2015008286A (es) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX366230B (es) | Composiciones multipolimericas para liberación transdermica de farmaco. | |
| MX2023000320A (es) | Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion. | |
| MY163809A (en) | Transdermal drug delivery system containing donepezil | |
| EP3583218A4 (en) | TARGETED ACTIVE SUBSTANCE RELEASE ON LIGAND PAYLOAD BASIS FOR CELL THERAPY | |
| WO2015165413A8 (zh) | 一种新型的稳定型抗体药物耦联物及其制备方法和用途 | |
| MX362838B (es) | Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente. | |
| EP3072506A4 (en) | Carrier for drug delivery and conjugate, composition containing same, and method for administering same | |
| EP2833849A4 (en) | INTRAOCULAR RELEASE DEVICES AND METHOD THEREFOR | |
| HK1203489A1 (en) | Purinone compounds as kinase inhibitors | |
| WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
| EP3275482A4 (en) | Syringe holder and medical solution administration set | |
| CY1120435T1 (el) | Φαρμακοτεχνικες μορφες που περιλαμβανουν κρυσταλλικες μορφες του μονοενυδρου υδροχλωρικου (r)-7-χλωρο-ν-(κινουκλιδινο-3-υλο) βενζο(β)θειοφαινο-2-καρβοξαμιδιου | |
| PH12015502280A1 (en) | Transdermal delivery system comprising donepezil or its salt | |
| EP3318879A4 (en) | Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag | |
| MX339196B (es) | Composiciones de aripiprazol y metodos para su suministro transdermico. | |
| AR094289A1 (es) | Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol | |
| PH12015502556A1 (en) | Modified release formulation | |
| EP3177270A4 (en) | Chemically stable and oromucosally absorbable gel compositions of a pharmaceutical active agent in a multi-chambered delivery system | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| GB201014391D0 (en) | Drug composition and its use in therapy | |
| MY166972A (en) | Transdermal delivery system containing galantamine or salts thereof | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX2015007731A (es) | Formulacion farmaceutica que comprende ciclesonida. | |
| EP3319613A4 (en) | Use of amine carboxyboranes as therapeutic delivery of carbon monoxide and as general drug delivery system in the presence of reactive oxygen species | |
| MX2015006997A (es) | Composicion farmaceutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |